Found: 22
Select item for more details and to access through your institution.
Follicular lymphoma with secondary central nervous system relapse: a case report and literature review.
- Published in:
- Oxford Medical Case Reports, 2023, v. 2023, n. 11, p. 1, doi. 10.1093/omcr/omad118
- By:
- Publication type:
- Article
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 595, doi. 10.1093/jjco/hyad027
- By:
- Publication type:
- Article
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2022, v. 52, n. 1, p. 29, doi. 10.1093/jjco/hyab170
- By:
- Publication type:
- Article
Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 1, p. 41, doi. 10.1007/s12185-013-1483-9
- By:
- Publication type:
- Article
Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Compression therapy using surgical gloves is ineffective for the prevention of vincristine-induced neuropathy in patients with malignant lymphoma.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 3, p. 1, doi. 10.1007/s00520-024-08389-3
- By:
- Publication type:
- Article
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard‐dose azacitidine.
- Published in:
- Cancer Reports, 2024, v. 7, n. 1, p. 1, doi. 10.1002/cnr2.1938
- By:
- Publication type:
- Article
ALK<sup>+</sup>, CD30<sup>-</sup>, CD20<sup>-</sup> Large B-Cell Lymphoma Containing Anaplastic Lymphoma Kinase (ALK) Fused to Clathrin Heavy Chain Gene (CLTC).
- Published in:
- Modern Pathology, 2003, v. 16, n. 8, p. 828, doi. 10.1097/01.MP.0000081729.40230.1F
- By:
- Publication type:
- Article
Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR<sup>4.5</sup>): The phase 2, multicenter N‐Road study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 11, p. 3742, doi. 10.1002/cam4.3034
- By:
- Publication type:
- Article
OPTIMISMM Japanese Subgroup Analysis: Pomalidomide, Bortezomib, and Dexamethasone in Relapsed or Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e270, doi. 10.1016/j.clml.2019.09.446
- By:
- Publication type:
- Article
Efficacy of Molecular Response at 1 or 3 Months after the Initiation of Dasatinib Treatment Can Predict an Improved Response to Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Japanese Patients with Chronic Myelogenous Leukemia during the Chronic Phase.
- Published in:
- Journal of Clinical & Experimental Hematopathology, 2014, v. 54, n. 3, p. 197, doi. 10.3960/jslrt.54.197
- By:
- Publication type:
- Article
Ixazomib-induced Sweet's syndrome.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23).
- Published in:
- Genes, Chromosomes & Cancer, 2007, v. 46, n. 9, p. 813, doi. 10.1002/gcc.20467
- By:
- Publication type:
- Article
Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.
- Published in:
- Acta Haematologica, 2019, v. 141, n. 2, p. 111, doi. 10.1159/000495338
- By:
- Publication type:
- Article
Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple Myeloma.
- Published in:
- Acta Haematologica, 2015, v. 134, n. 1, p. 25, doi. 10.1159/000369445
- By:
- Publication type:
- Article
Pomalidomide‐bortezomib‐dexamethasone in relapsed or refractory multiple myeloma: Japanese subset analysis of OPTIMISMM.
- Published in:
- Cancer Science, 2020, v. 111, n. 6, p. 2116, doi. 10.1111/cas.14415
- By:
- Publication type:
- Article
Lenalidomide and low-dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study.
- Published in:
- Cancer Science, 2016, v. 107, n. 5, p. 653, doi. 10.1111/cas.12916
- By:
- Publication type:
- Article
Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response.
- Published in:
- NPJ Systems Biology & Applications, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41540-022-00248-3
- By:
- Publication type:
- Article
Ex Vivo Induction of mRNA in Human Whole Blood as a New Platform of Drug and Dietary Supplement Development.
- Published in:
- Pharmaceutical Research, 2008, v. 25, n. 5, p. 1116
- By:
- Publication type:
- Article
Megakaryopoiesis in patients with cyclic thrombocytopenia.
- Published in:
- British Journal of Haematology, 1995, v. 91, n. 1, p. 185, doi. 10.1111/j.1365-2141.1995.tb05267.x
- By:
- Publication type:
- Article